EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,000 | -55.0% | 316 | -57.6% | 0.00% | – |
| Q3 2022 | $20,000 | -4.8% | 745 | +61.3% | 0.00% | – |
| Q2 2022 | $21,000 | +75.0% | 462 | +92.5% | 0.00% | – |
| Q1 2022 | $12,000 | -98.5% | 240 | -98.3% | 0.00% | -100.0% |
| Q3 2019 | $816,000 | +92.5% | 14,423 | +89.2% | 0.00% | +100.0% |
| Q2 2019 | $424,000 | +0.5% | 7,622 | -8.8% | 0.00% | 0.0% |
| Q1 2019 | $422,000 | +25.2% | 8,360 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $337,000 | +200.9% | 8,360 | +415.4% | 0.00% | +100.0% |
| Q3 2018 | $112,000 | -74.4% | 1,622 | -80.5% | 0.00% | -50.0% |
| Q1 2018 | $438,000 | +0.2% | 8,308 | +1.6% | 0.00% | 0.0% |
| Q4 2017 | $437,000 | -66.4% | 8,180 | -50.4% | 0.00% | -50.0% |
| Q2 2017 | $1,300,000 | – | 16,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |